The A-share flu vaccine sector fluctuated higher, with Zhong Sheng Pharmaceutical hitting its second consecutive daily limit, Da An Gene hitting its daily limit, and Hualan Vaccine, Orient Bio, Aotai Bio, Lianhuan Pharmaceutical, and Zhijiang Bio following suit.